Contact our responsive and friendly client services team any time.
(03) 9028 2888
clients@freshequities.com
INVESTOR PRESENTATION - AdAlta Limited
Health
AdAlta is an innovative biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and then developed as a human protein. The result is a range of unique compounds, now known as i-bodies, for use in treating serious diseases. AdAlta is utilising the power of the i-body technology to create a pipeline of new drugs, with an initial focus on treating fibrotic diseases.
Read moreMarket Cap
Price at Close
4w avg. Volume
4w avg. Turnover
announcement | t+2 movement | date |
---|---|---|
| -7.69% | 13 Dec 2020 |
| 0.00% | 29 Nov 2020 |
| 0.00% | 26 Nov 2020 |
| 0.00% | 25 Nov 2020 |
| 0.00% | 24 Nov 2020 |
| 0.00% | 23 Nov 2020 |
| -4.35% | 08 Nov 2020 |
| -8.00% | 26 Oct 2020 |
| +3.70% | 21 Oct 2020 |
| +3.70% | 21 Oct 2020 |
Current Price
52WK HIGH
52WK LOW
1YR RETURN
1YR RETURN VS. SECTOR
90 DAY RETURN
ASX RANK
/2,047
SECTOR RANK
/168
SHARES OUTSTANDING
Health
AdAlta is an innovative biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and then developed as a human protein. The result is a range of unique compounds, now known as i-bodies, for use in treating serious diseases. AdAlta is utilising the power of the i-body technology to create a pipeline of new drugs, with an initial focus on treating fibrotic diseases.
Read moreMarket Cap
Price at Close
4w avg. Volume
4w avg. Turnover
ASX:1AD is not raising right now
Want to invest?
(03) 9028 2888
clients@freshequities.com
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia